Volume 94 Issue 36 | p. 15 | Concentrates
Issue Date: September 12, 2016

Cambrex expands next in Sweden

Department: Business
Keywords: pharmaceutical chemicals, active pharmaceutical ingredient
[+]Enlarge
Cambrex will invest $9 million in this Swedish facility.
Credit: Cambrex
A photo of Cambrex’s facility in Sweden.
 
Cambrex will invest $9 million in this Swedish facility.
Credit: Cambrex

Cambrex will spend $9 million to expand its small-molecule active pharmaceutical ingredient (API) facility in Karlskoga, Sweden. The investment will add 28 m3 of capacity at the site, roughly a 10% increase, according to Cambrex. “This investment is in response to an increase in demand for larger-scale, multipurpose manufacturing capabilities, says Bjarne Sandberg, managing director of Cambrex Karlskoga. Cambrex recently invested $50 million in its Charles City, Iowa, API facility and said it would spend $20 million on further expansion by year-end.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment